BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Treatment
16748 results:

  • 1. A Rare Case of Congenital Nephrogenic Diabetes Insipidus Associated with Aquaporin 2 Gene Mutation and Subsequent Acute Lymphoblastic leukemia: Impact of Steroids on Kidney Function.
    Al-Thiabat H; Abu-Aqoulah A; Kanaan D; Matalka MI; Al-Sweedan S
    Am J Case Rep; 2024 May; 25():e943597. PubMed ID: 38769718
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Concomitantly Diagnosed Disseminated
    Stanton DJ; Quadri NZ; Tanabe MB
    J Investig Med High Impact Case Rep; 2024; 12():23247096241253343. PubMed ID: 38767131
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Cytoreductive chemotherapy in induction therapy plays a key role in the prognosis of patients with low-risk acute promyelocytic leukaemia.
    Zhu X; Tang F; Yu W; Zhao X; Qin Y; Jiang Q; Huang X; Jiang H
    J Cell Mol Med; 2024 May; 28(10):e18252. PubMed ID: 38766688
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pharmacogenomics, Race, and treatment Outcome in Pediatric Acute Myeloid leukemia.
    Lamba JK; Marrero R; Wu H; Cao X; Parcha PK; Karol SE; Inaba H; Kuo DJ; Degar BA; Heym K; Taub JW; Lacayo NJ; Pui CH; Ribeiro RC; Pounds SB; Rubnitz JE
    JAMA Netw Open; 2024 May; 7(5):e2411726. PubMed ID: 38753328
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Therapeutic Choices in Patients with Ph-Positive Chronic Myelogenous leukemia In Mexico in the Era of Tyrosine Kinase Inhibitors: Stem Cell Transplantation or Tyrosine Kinase Inhibitors? Fifteen Years Later.
    Max RN; Daniela SB; Moisés M GP; Edgar J HF; Merittzel A MR; María de L PM; Juan C OG; Guillermo J RD; Guillermo J RA
    Rev Invest Clin; 2024; 76(2):91-96. PubMed ID: 38740380
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Valrubicin-loaded immunoliposomes for specific vesicle-mediated cell death in the treatment of hematological cancers.
    Georgievski A; Bellaye PS; Tournier B; Choubley H; Pais de Barros JP; Herbst M; Béduneau A; Callier P; Collin B; Végran F; Ballerini P; Garrido C; Quéré R
    Cell Death Dis; 2024 May; 15(5):328. PubMed ID: 38734740
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. (2,6-Dimethylphenyl)arsonic Acid Induces Apoptosis through the Mitochondrial Pathway, Downregulates XIAP, and Overcomes Multidrug Resistance to Cytostatic Drugs in leukemia and Lymphoma Cells In Vitro.
    Wilke N; Frias C; Berkessel A; Prokop A
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731935
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Systems Biology for Drug Target Discovery in Acute Myeloid leukemia.
    Novikova S; Tolstova T; Kurbatov L; Farafonova T; Tikhonova O; Soloveva N; Rusanov A; Zgoda V
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731835
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Efficacy of surgical treatment of perianal infection in patients with hematological malignancy.
    He J; Ni Z; Li Z
    Medicine (Baltimore); 2024 May; 103(19):e38082. PubMed ID: 38728504
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Philadelphia chromosome-positive acute myeloid leukemia successfully treated by allogeneic hematopoietic stem cell transplantation: A case report and review of the literature.
    Zhang Z; Wang X; Bai J; Yang X; Lian B; Zhang Y; Kang J; Pan Y
    Medicine (Baltimore); 2024 May; 103(19):e38110. PubMed ID: 38728478
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Systematic analysis of mucosal-associated invariant T cells in haematological malignancies.
    Bacova B; Cierny J; Nemcekova L; Smetanova/Brozova J; Novak J
    Scand J Immunol; 2024 Jun; 99(6):e13364. PubMed ID: 38720521
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Regulation of cytokine and chemokine expression by histone lysine methyltransferase MLL1 in rheumatoid arthritis synovial fibroblasts.
    Okamoto K; Araki Y; Aizaki Y; Tanaka S; Kadono Y; Mimura T
    Sci Rep; 2024 May; 14(1):10610. PubMed ID: 38719857
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [The value of minimal residual disease and IKZF1 deletion for predicting prognosis in adult patients with B-cell acute lymphoblastic leukemia].
    Deng SY; Ou JW; Huang ZC; Chen JJ; Cai ZH; Liu QF; Zhou HS
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):257-263. PubMed ID: 38716597
    [No Abstract]    [Full Text] [Related]  

  • 14. [treatment status of tyrosine kinase inhibitor for newly-diagnosed chronic myeloid leukemia: a domestic multi-centre retrospective real-world study].
    Zhang XS; Liu BC; Du X; Zhang YL; Xu N; Liu XL; Li WM; Lin H; Liang R; Chen CY; Huang J; Yang YF; Zhu HL; Pan L; Wang XD; Li GH; Liu ZG; Zhang YQ; Liu ZF; Hu JD; Liu CS; Li F; Yang W; Meng L; Han YQ; Lin LE; Zhao ZY; Tu CQ; Zheng CF; Bai YL; Zhou ZP; Chen SN; Qiu HY; Yang LJ; Sun XL; Sun H; Zhou L; Liu ZL; Wang DY; Guo JX; Pang LP; Zeng QS; Suo XH; Zhang WH; Zheng YJ; Jiang Q
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):215-224. PubMed ID: 38716592
    [No Abstract]    [Full Text] [Related]  

  • 15. A phase 3b study of venetoclax and azacitidine or decitabine in an outpatient setting in patients with acute myeloid leukemia.
    Manda S; Anz BM; Benton C; Broun ER; Yimer HA; Renshaw JS; Geils G; Berdeja J; Cruz J; Melear JM; Fanning S; Fletcher L; Li Y; Duan Y; Werner ME; Potluri J; Pai MV; Donnellan WB
    Hematol Oncol; 2024 May; 42(3):e3274. PubMed ID: 38711253
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial.
    Burris HA; Okusaka T; Vogel A; Lee MA; Takahashi H; Breder V; Blanc JF; Li J; Bachini M; Żotkiewicz M; Abraham J; Patel N; Wang J; Ali M; Rokutanda N; Cohen G; Oh DY
    Lancet Oncol; 2024 May; 25(5):626-635. PubMed ID: 38697156
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Testing an Intervention to Improve Health Care Worker Well-Being During the COVID-19 Pandemic: A Cluster Randomized Clinical Trial.
    Meredith LS; Ahluwalia S; Chen PG; Dong L; Farmer CM; Bouskill KE; Dalton S; Qureshi N; Blagg T; Timmins G; Schulson LB; Huilgol SS; Han B; Williamson S; Watson P; Schnurr PP; Martineau M; Davis K; Cassells A; Tobin JN; Gidengil C
    JAMA Netw Open; 2024 Apr; 7(4):e244192. PubMed ID: 38687482
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Acute myeloid leukemia with central nervous system involvement successfully treated with gilteritinib].
    Koyama G; Kawaguchi T; Sato T; Hamada C; Hara S
    Rinsho Ketsueki; 2024; 65(4):231-236. PubMed ID: 38684432
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Increased Th17 and Treg levels in peripheral blood positively correlate with minimal residual disease in acute myeloid leukaemia.
    Wang Z; Liu T; Li Y; Li Z; Bi K
    Hematology; 2024 Dec; 29(1):2346971. PubMed ID: 38682816
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi-state modeling.
    Hermans SJF; van Norden Y; Versluis J; Rijneveld AW; van der Holt B; de Weerdt O; Biemond BJ; van de Loosdrecht AA; van der Wagen LE; Bellido M; van Gelder M; van der Velden WJFM; Selleslag D; van Lammeren-Venema D; van der Velden VHJ; de Wreede LC; Postmus D; Pignatti F; Cornelissen JJ
    Cancer Med; 2024 May; 13(9):e6756. PubMed ID: 38680089
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 838.